C12N 2750/14123
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2750/14123 (Virus like particles [vlp]) appears on 70 US grants and 171 published applications in this corpus.
Search patents in C12N- Granted patents
- 70
- Published applications
- 171
- Assignees
- 110
- Inventors
- 368
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 1 |
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 3 |
| 2013 | 0 | 1 |
| 2014 | 0 | 3 |
| 2015 | 0 | 3 |
| 2016 | 2 | 1 |
| 2017 | 4 | 4 |
| 2018 | 3 | 2 |
| 2019 | 1 | 10 |
| 2020 | 4 | 16 |
| 2021 | 6 | 24 |
| 2022 | 5 | 34 |
| 2023 | 7 | 24 |
| 2024 | 13 | 11 |
| 2025 | 14 | 14 |
| 2026 | 7 | 14 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Online native mass spectrometry methods for assaying viral particles11 Aug 2026US 12,704,515 B2Regeneron Pharmaceuticals, Inc.
- Use of alginate oligomers to enhance the translocation of micro/nanoparticles across mucus layers9 Jun 2026US 12,649,000 B2Algipharma AS
- AAV6 variants12 May 2026US 12,624,367 B2University of Florida Research Foundation, Inc.
- Method for producing nucleic acid-encapsulated AAV hollow particle21 Apr 2026US 12,606,845 B2Nippon Medical School Foundation
- Engineered viral capsid polypeptides and uses thereof21 Apr 2026US 12,606,847 B2President and Fellows of Harvard College
- Use of alginate oligomers to enhance the translocation of micro/nanoparticles across mucus layers1 Oct 2026US 2026/0295071 A1Algipharma AS
- Use of prime editing in correcting mutations in cdkl520 Aug 2026US 2026/0242800 A1President and Fellows of Harvard College
- Culture medium composition9 Jul 2026US 2026/0193619 A1Ajinomoto Co., Inc.
- Engineered muscle targeting compositions7 May 2026US 2026/0125706 A1Massachusetts Institute of Technology
- Liver-specific viral promoters and methods of using the same30 Apr 2026US 2026/0117251 A1uniQure IP B.V.
Most cited
By later US patents
- AAV capsid vehicles for molecular transfer141US 6,204,059 B1University of Pittsburgh · 2001
- AAV capsid vehicles for molecular transfer92US 5,863,541 AUniversity of Pittsburgh · 1999
- AAV vectors with high transduction efficiency and uses thereof for gene therapy57US 9,725,485 B2University of Florida Research Foundation, Inc. · 2017
- Methods of predicting ancestral virus sequences and uses thereof55US 9,695,220 B2Massachusetts Eye and Ear Infirmary · 2017
- Methods of predicting ancestral virus sequences and uses thereof47US 9,719,070 B2Massachusetts Eye and Ear Infirmary · 2017